1. Combination curcumin and (−)-epigallocatechin-3-gallate inhibits colorectal carcinoma microenvironment-induced angiogenesis by JAK/STAT3/IL-8 pathway
   G Jin et al, 2017, Oncogenesis CrossRef
2. Establishment and evaluation of four different types of patient-derived xenograft models
   Xiaoqian Ji et al, 2017, Cancer Cell Int CrossRef
3. Establishment and genomic characterizations of patient-derived esophageal squamous cell carcinoma xenograft models using biopsies for treatment optimization
   Jianling Zou et al, 2018, J Transl Med CrossRef
4. Establishment of lung cancer patient-derived xenograft models and primary cell lines for lung cancer study
   Yanan Jiang et al, 2018, J Transl Med CrossRef
5. Tumor xenograft animal models for esophageal squamous cell carcinoma
   Nikki P. Lee et al, 2018, J Biomed Sci CrossRef
6. Clinical and translational advances in esophageal squamous cell carcinoma.
   Zachary Wilmer Reichenbach et al, 2019, Adv Cancer Res CrossRef
7. Constitutive activated STAT3 is an essential regulator and therapeutic target in esophageal squamous cell carcinoma
   Fang Tian et al, 2017, Oncotarget CrossRef
8. Metformin inhibits esophageal squamous cell carcinoma-induced angiogenesis by suppressing JAK/STAT3 signaling pathway.
   Yi Yang et al, 0 CrossRef
9. Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma
   Jingzhen Shi et al, 2020, Front. Oncol. CrossRef
10. Mefloquine Inhibits Esophageal Squamous Cell Carcinoma Tumor Growth by Inducing Mitochondrial Autophagy
    Yifei Xie et al, 2020, Front. Oncol. CrossRef
11. Patient-derived xenograft: a developing tool for screening biomarkers and potential therapeutic targets for human esophageal cancers
    Tianfeng Lan et al, 2021, Aging CrossRef
12. BRD4 drives esophageal squamous cell carcinoma growth by promoting RCC2 expression
    Qiong Wu et al, 2021, Oncogene CrossRef
13. Repurposed benzydamine targeting CDK2 suppresses the growth of esophageal squamous cell carcinoma
    Yubing Zhou et al, 2022, Front. Med. CrossRef
14. Prediction of pathological response grading for esophageal squamous carcinoma after neoadjuvant chemoradiotherapy based on MRI imaging using PDX
    Jingzhen Shi et al, 2023, Front. Oncol. CrossRef